Eli Lilly and Company

Clinical Research Physician- Oncology Global Medical Affairs

Chester, Maryland, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, OncologyIndustries

Requirements

Candidates must be a licensed physician with a medical degree and board certification in clinical medicine, specifically with a strong background in oncology. Applicants should possess a thorough understanding of clinical trial design and execution, as well as demonstrated experience in conducting and analyzing clinical research. Prior experience in global medical affairs or pharmaceutical development is highly desirable.

Responsibilities

The Clinical Research Physician will provide expert medical and scientific support throughout the drug development lifecycle, including supporting strategic planning, drug development, and commercialization activities. They will engage with external customers such as oncologists and payers, generate critical scientific evidence, disseminate scientific data, and contribute to the development of medical strategies. The role involves identifying evidence gaps, driving scientific disclosure, collaborating with clinical development, and supporting internal field training, all with a primary focus on thoracic oncology.

Skills

Medical expertise
Clinical research
Oncology
Scientific support
Drug development
Strategic planning
Medical communication

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI